Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial.
Schmidinger M, Budinsky AC, Wenzel C, Locker GJ, Pluschnig U, Brodowicz T, Kubista E, Maca S, Zabernigg A, Ilsinger P, Seewann L, Hojas S, Blach M, Zielinski CC, Steger GG.
Schmidinger M, et al. Among authors: zielinski cc.
Cancer Chemother Pharmacol. 2001;47(1):57-62. doi: 10.1007/s002800000204.
Cancer Chemother Pharmacol. 2001.
PMID: 11221963